The definition of a haemodynamic significant duct in randomized controlled trials: A systematic literature review

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 3, 2012, Pages 247-251

  Zonnenberg, Inge ^a   De Waal, Koert ^b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Ductus arteriosus; Newborn; Systematic review

Indexed keywords

BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; CLINICAL EXAMINATION; COCHRANE LIBRARY; CONGESTIVE HEART FAILURE; DOPPLER FLOWMETRY; HEART LEFT RIGHT SHUNT; HEART MURMUR; HEART SIZE; HEMODYNAMICALLY SIGNIFICANT DUCTUS ARTERIOSUS; HUMAN; LEFT ATRIUM TO AORTA RATIO; MEDLINE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ULTRASOUND;

DUCTUS ARTERIOSUS, PATENT; HEMODYNAMICS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRASONOGRAPHY, DOPPLER;

EID: 84856361450     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02468.x     Document Type: Review

References (27)

1. Clyman RI, Chorne N,. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007; 150: 216-9. (Pubitemid 46328984)
2. Teixeira LS, McNamara PJ,. Enhanced intensive care for the neonatal ductus arteriosus. Acta Paediatr 2006; 95: 394-403. (Pubitemid 43739063)
3. Cooke L, Steer P, Woodgate P,. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; 2: CD003745.
4. Fowlie PW, Davis PG, McGuire W,. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010; 2: CD000174.
5. Ohlsson A, Walia R, Shah SS,. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010; 14: CD003481.
6. Shah SS, Ohlsson A,. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3: CD004213.
7. Malviya M, Ohlsson A, Shah S,. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2008; 1: CD003951.
8. Mosalli R, Alfaleh K,. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008; 1: CD006181.
9. Herrera C, Holberton J, Davis P,. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2007; 2: CD003480.
10. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A,. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150: 229-34.
11. Benitz WE,. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30: 241-52.
12. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, et al., A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009; 26: 235-45.
13. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, et al., Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005; 115: 1529-35. (Pubitemid 43843160)
14. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, et al., Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939-44. (Pubitemid 39574596)
15. Sangtawesin V, Sangtawesin C, Raksasinborisut C, Sathirakul K, Kanjanapattanakul W, Khorana M, et al., Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai 2006; 89: 314-21.
16. Sangtawesin C, Sangtawesin V, Lertsutthiwong W, Kanjanapattanakul W, Khorana M, Ayudhaya JK,. Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants. J Med Assoc Thai 2008; 91: S28-34.
17. van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwé W, Jespers A, et al., Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1945-9. (Pubitemid 39574597)
18. Australian New Zealand Clinical Trials Registry. Targeting of treatment of the patent ductus arteriosus using early echocardiography (DETECT). ID# ACTRN 12608000295347. Available at. (accessed on June 15, 2011).
19. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, et al., Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000; 89: 1369-74.
20. van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P,. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001; 138: 205-11. (Pubitemid 32156435)
21. Kluckow M, Evans N,. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127: 774-9.
22. Evans N, Iyer P,. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995; 72: F156-61.
23. Groves AM, Kuschel CA, Knight DB, Skinner JR,. Does retrograde diastolic flow in the descending aorta signify impaired systemic perfusion in preterm infants? Pediatr Res 2008; 63: 89-94.
24. Condò M, Evans N, Bellù R, Kluckow M,. Echocardiographic assessment of ductal significance: retrospective comparison of two methods. Arch Dis Child Fetal Neonatal Ed 2011; May 5 [Epub ahead of print].
25. Iyer P, Evans N,. Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 1994; 70: F112-7. (Pubitemid 24127889)
26. McNamara PJ, Sehgal A,. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007; 92: F424-7. (Pubitemid 350043994)
27. Bose CL, Laughon MM,. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92: F498-502. (Pubitemid 350063851)